Purchase this article with an account.
Peter H. Tang, Jie Fan, Patrice W. Goletz, Lee Wheless, Rosalie K. Crouch; Effective and Sustained Delivery of Hydrophobic Retinoids to Photoreceptors. Invest. Ophthalmol. Vis. Sci. 2010;51(11):5958-5964. doi: 10.1167/iovs.10-5766.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Delivery of hydrophobic compounds to the retina/RPE has been challenging. The purpose of this study was to develop an effective method for the sustained delivery of retinoids to rod and cone photoreceptors of young mice lacking a normal supply of 11-cis retinal.
Solubilized basement membrane matrix (Matrigel; BD Biosciences, San Jose, CA) loaded with 9-cis retinal was administered subcutaneously into Rpe65 −/− mouse pups for assessment of delivery to rods and cones and to Rpe65 −/− Rho −/− mouse pups for assessment of delivery to cones. Intraperitoneal injections of 9-cis retinal were used for comparison. Cone density and opsin localization were evaluated with immunohistochemistry. Cone opsin protein levels were assayed with immunoblots, and cone function was analyzed by electroretinography (ERG) recordings. Retinoid content was determined by high-performance liquid chromatography analysis of retinal extracts. Pigment levels were quantified in homogenized retinas by absorption spectroscopy before and after light exposure.
Single administration of Matrigel loaded with 9-cis retinal to Rpe65 −/− mice increased cone densities in all analyzed regions of the retina compared with mice treated using intraperitoneal delivery. Cone opsin levels increased to near wild-type levels. Similar treatment in Rpe65 −/− Rho −/− mice increased b-wave ERG amplitudes significantly, indicating the maintenance of cone function. Matrigel was shown to continuously release 9-cis retinal for periods up to 1 week.
As a method for sustained drug delivery, subcutaneous administration using Matrigel proved more efficacious than intraperitoneal injection for in vivo delivery of retinoids to cone photoreceptors. These experiments are the first to show a sustained delivery of retinoids in mice and suggest a strategy for potential clinical therapeutic development.
This PDF is available to Subscribers Only